SCOTT CHAPPEL
Profile
First Name
: SCOTT
Middle Name
:
Last Name
: CHAPPEL
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
REINHARD AMBROS, REINHARD J. AMBROS, TIMOTHY BARBERICH, TIMOTHY J. BARBERICH, EREZ CHIMOVITS, CHERYL COHEN, GREGORY FLESHER, DAVID-ALEXANDRE GROS, SETH L. HARRISON, JAN HILLSON, KEITH KATKIN, KEITH A. KATKIN, DAVID KESSLER, DAVID A. KESSLER, ALLAN KIRK, JON KUWAHARA, JUNE LEE, PAUL LITTLE, GARY LYONS, GARY A. LYONS, JOHN MCBRIDE, JODIE P. MORRISON, CAMPBELL MURRAY, WALTER OGIER, STEVEN PERRIN, STEVEN N. PERRIN, JAMES ROBINSON, BRYAN SMITH, CATHERINE TURKEL, JOSEPH A. YANCHIK, III
EXECUTIVE OFFICER
RICHARD ALDRICH, MATTHEW ANGEL, CHRISTOPHER A. BLECK, STEPHEN BRADY, STEPHEN R. BRADY, JEFF CAPELLO, MICHELLE DIPP, THOMAS W. DUBENSKY, MICHAEL FLANAGAN, STEPHEN KRAUS, ALISON LAWTON, NICHOLAS MAESTAS, THOMAS MALLEY, GEOFFREY NICHOL, CHRISTINE PELLIZZARI, MICHAEL RAAB, WILLIAM DRAKE RICHEY, RONIT SIMANTOV, JOHN SIMON, HARALD STOCK, JONATHAN TILLY, JUSTIN TROJANOWSKI, CHRISTOPH WESTPHAL, THOMAS WOIWODE, JOHN DAVID YEE
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2013-03-18
D/A
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2012-06-21
D/A
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2012-06-21
D/A
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2012-06-21
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2012-06-21
